Medicine composition for treating chronic liver disease
A chronic liver disease and composition technology, applied in the field of pharmaceutical composition for the treatment of chronic liver disease, can solve the problems of not very obvious effect, inconvenient preparation and use, unstable curative effect, etc., achieve exact therapeutic effect, short course of treatment, rigorous and novel prescription Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Embodiment 1 pharmaceutical composition one
[0026] 20 parts of kiwi juice, 30 parts of Danshen, 5 parts of Atractylodes macrocephala, 12 parts of Epimedium, 4 parts of Poria, 6 parts of Bupleurum, 5 parts of Schisandra, 4.5 parts of Baikou, 2.5 parts of tangerine peel, and 15 parts of heterophylla.
Embodiment 2
[0027] Example 2 Pharmaceutical composition two
[0028] 24 parts of kiwi juice, 28 parts of Danshen, 6 parts of Atractylodes macrocephala, 11 parts of Epimedium, 5 parts of Poria, 5 parts of Bupleurum, 6 parts of Schisandra, 4 parts of Baikou, 3 parts of tangerine peel, and 14 parts of heterophylla.
Embodiment 3
[0029] Example 3 Pharmaceutical composition three
[0030] 28 parts of kiwi juice, 26 parts of Danshen, 7 parts of Atractylodes macrocephala, 10 parts of Epimedium, 6 parts of Poria, 4 parts of Bupleurum, 7 parts of Schisandra, 3.5 parts of Baikou, 3.5 parts of tangerine peel, and 13 parts of heterophylla.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com